| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000259462.1 |
Bexarotene |
Bladder urothelial carcinoma |
0.031514007 |
Resistant |
| ENSG00000259462.1 |
Bexarotene |
Lung squamous cell carcinoma |
0.025008511 |
Resistant |
| ENSG00000259462.1 |
Bexarotene |
Skin cutaneous melanoma |
0.027667188 |
Resistant |
